ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

American College of Allergy, Asthma and Immunology (ACAAI) 

85 West Algonquin Road
Suite 550
Arlington Heights  Illinois  60005  U.S.A.
Phone: 847-427-1200 Fax: 847-427-1294


SEARCH JOBS








 Company News
People Who Have Asthma May Be Prone To Bone Loss, American College of Allergy, Asthma and Immunology (ACAAI) Reveals 5/8/2014 6:37:18 AM
ViroPharma Incorporated (VPHM) Announces Upcoming Data Presentations at the 2013 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting 11/7/2013 6:11:45 AM
Children With Allergy, Asthma May be at Higher Risk for ADHD, American College of Allergy, Asthma and Immunology (ACAAI) Reveals 8/14/2013 6:20:54 AM
Living Near Equator May Boost Your Risk for Allergy, Asthma, American College of Allergy, Asthma and Immunology (ACAAI) Study 2/5/2013 7:25:29 AM
Food Allergies? Pesticides in Tap Water Might be to Blame, American College of Allergy, Asthma and Immunology (ACAAI) Reveals 12/3/2012 7:55:34 AM
Dyax Corp. (DYAX) Announces Presentation of KALBITOR® (ecallantide) Pediatric and Abdominal Attack Data at the American College of Allergy, Asthma and Immunology (ACAAI) 11/13/2012 10:23:29 AM
Sunovion Pharmaceuticals Inc. Presents New Clinical Safety Data From the Pediatric Development Program for ZETONNA® (ciclesonide) Nasal Aerosol at American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting 11/12/2012 9:55:49 AM
Asthma Linked to Genetics, American College of Allergy, Asthma and Immunology (ACAAI) Reveals 11/12/2012 6:07:46 AM
Aerocrine: The American Thoracic Society & AAAAI Issue a Joint Position Statement in Support of the American Thoracic Society Guidelines on FeNO 4/2/2012 10:56:39 AM
Baxter International, Inc. (BAX) Presents Phase III HyQ Efficacy and Tolerability Data at American College of Allergy, Asthma and Immunology (ACAAI) Meeting 11/7/2011 8:12:01 AM
1234